Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Think Research Corporation THKKF


Primary Symbol: V.THNK

Think Research Corporation is a Canada-based company that offers digital health software solutions. It is a provider of cloud-based data, knowledge, and software solutions primarily delivered as software-as-a-service (SaaS) to healthcare delivery systems and the practitioners that they support. Its operations are organized into three lines of business: Software and Data Solutions, Clinical Research, and Clinical Services. Its SaaS solutions help patients find, navigate, and connect to health services across large governments and payer clients, while also ensuring safety for prescribed medications at pharmacies. Through its wholly owned subsidiary, BioPharma Services Inc., the Company provides research data and analysis derived from Phase I clinical trials, bioequivalence studies and bioanalytical services. Its clinics act as a test bed for its software and technology, transforming them with digital solutions that optimize clinical outcomes, streamline workflows, and optimize billing.


TSXV:THNK - Post by User

Comment by AlwaysLong683on Feb 19, 2022 1:45pm
116 Views
Post# 34445074

RE:RE:Desjardins comment on 6 healthcare stocks - cantechletter

RE:RE:Desjardins comment on 6 healthcare stocks - cantechletterI "think" Think would be foolish to even entertain making another acquisition for the forseeable future unless they want to do an equity raise at a discount to whatever their average share price is (likely over a 30-day period), which is probably what it would take to entice underwriters or private placement investors to take the shares. So if you view this as shareholder dilution, it is is not a great option IMO.

Taking on debt? If they are trying to pay down debt, first they would have to generate the cash to do so. If they accomplish their debt reduction goals, why would they turn around and take on more debt to finance an acquisition, likely at even higher interest rates than they pay now if the BOC boosts them as expected this year, not to mention the premium on top of that lenders would likely ask for given the size of the company? I find these companies that are serial acquirers yet don't have either the share price or the low debt to do so without doing damage to existing shareholders or their balance sheet play a very risky game, and it shows in the current share price of THNK even if you take into account the drop in share price that many other Canadian small cap stocks have experienced in the "tech wreck" of 2021 and now into 2022.

Re. being taken out: Would large shareholders be willing to vote in favour of a takeout if the price offered was / is considerably lower than the average cost per share they paid unless they believe they've made a big mistake investing in the company in the first place and just want to exit the name? 

Re. expiration of options: I believe Boards often simply offer another block of options at lower strike prices to individuals in top posts, so they get a fresh start in terms of exercising them.

IMO the best route for THNK to go is simply work with what they currently own to attain profitability while strengthening their balance sheet. Many investors think the more acquisitions, the bigger and thus better the company is, but there is a cost to acquiring a company, and if it proves not to pay off in the way expected, the acquistion will have untlimately hurt the company, not strengthened it.


<< Previous
Bullboard Posts
Next >>